 Vanja Dukic
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Moths | 6 | 2024 | 45 | 2.150 |
Why?
| | Models, Biological | 7 | 2024 | 1783 | 1.370 |
Why?
| | Population Dynamics | 4 | 2024 | 151 | 1.090 |
Why?
| | Mathematical Concepts | 2 | 2023 | 31 | 1.000 |
Why?
| | Epidemics | 2 | 2020 | 89 | 0.980 |
Why?
| | Models, Statistical | 7 | 2017 | 669 | 0.830 |
Why?
| | Nonlinear Dynamics | 1 | 2023 | 88 | 0.800 |
Why?
| | Smoking | 7 | 2012 | 1627 | 0.740 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2014 | 234 | 0.700 |
Why?
| | Whooping Cough | 1 | 2019 | 51 | 0.640 |
Why?
| | Public Health Surveillance | 1 | 2019 | 82 | 0.630 |
Why?
| | Staphylococcal Infections | 3 | 2014 | 400 | 0.620 |
Why?
| | Self Disclosure | 2 | 2009 | 63 | 0.570 |
Why?
| | Smallpox | 2 | 2013 | 9 | 0.480 |
Why?
| | Pregnancy Complications | 3 | 2012 | 527 | 0.470 |
Why?
| | Survival Analysis | 1 | 2017 | 1325 | 0.420 |
Why?
| | Bayes Theorem | 5 | 2014 | 405 | 0.390 |
Why?
| | Monte Carlo Method | 4 | 2020 | 148 | 0.390 |
Why?
| | Warfare | 2 | 2011 | 68 | 0.370 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 364 | 0.350 |
Why?
| | Community-Acquired Infections | 1 | 2013 | 174 | 0.340 |
Why?
| | Cotinine | 2 | 2009 | 77 | 0.340 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1266 | 0.330 |
Why?
| | Maternal Exposure | 3 | 2012 | 190 | 0.330 |
Why?
| | General Surgery | 1 | 2011 | 173 | 0.300 |
Why?
| | Biological Assay | 1 | 2009 | 124 | 0.300 |
Why?
| | Periodicals as Topic | 1 | 2011 | 211 | 0.290 |
Why?
| | Population Surveillance | 1 | 2011 | 482 | 0.280 |
Why?
| | Baculoviridae | 2 | 2020 | 44 | 0.280 |
Why?
| | Ecosystem | 2 | 2024 | 596 | 0.270 |
Why?
| | Internet | 1 | 2011 | 655 | 0.260 |
Why?
| | Geography | 2 | 2019 | 200 | 0.250 |
Why?
| | Models, Psychological | 2 | 2011 | 301 | 0.250 |
Why?
| | Larva | 3 | 2023 | 226 | 0.240 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2008 | 1079 | 0.230 |
Why?
| | Biomedical Research | 1 | 2011 | 692 | 0.230 |
Why?
| | Antipsychotic Agents | 1 | 2006 | 194 | 0.220 |
Why?
| | Wounds and Injuries | 1 | 2011 | 758 | 0.220 |
Why?
| | Prenatal Exposure Delayed Effects | 4 | 2012 | 605 | 0.210 |
Why?
| | Biometry | 1 | 2003 | 70 | 0.210 |
Why?
| | Cannibalism | 1 | 2023 | 3 | 0.200 |
Why?
| | Systems Biology | 1 | 2023 | 67 | 0.200 |
Why?
| | Tobacco Smoke Pollution | 3 | 2012 | 261 | 0.190 |
Why?
| | Schizophrenia | 1 | 2006 | 439 | 0.190 |
Why?
| | Host-Parasite Interactions | 1 | 2023 | 114 | 0.180 |
Why?
| | Insecta | 1 | 2021 | 67 | 0.180 |
Why?
| | Algorithms | 2 | 2023 | 1704 | 0.180 |
Why?
| | Basic Reproduction Number | 1 | 2020 | 5 | 0.170 |
Why?
| | Pregnancy | 11 | 2012 | 6763 | 0.170 |
Why?
| | Computer Simulation | 2 | 2020 | 978 | 0.170 |
Why?
| | Entomophthorales | 1 | 2020 | 1 | 0.170 |
Why?
| | Public Health Informatics | 1 | 2019 | 10 | 0.160 |
Why?
| | Humans | 29 | 2023 | 137585 | 0.160 |
Why?
| | Insect Control | 1 | 2020 | 16 | 0.160 |
Why?
| | Search Engine | 1 | 2019 | 12 | 0.160 |
Why?
| | Animals | 8 | 2024 | 36940 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3284 | 0.160 |
Why?
| | Weather | 1 | 2020 | 40 | 0.160 |
Why?
| | Social Class | 2 | 2019 | 282 | 0.160 |
Why?
| | Breast Neoplasms | 2 | 2008 | 2253 | 0.150 |
Why?
| | Morbidity | 1 | 2019 | 324 | 0.150 |
Why?
| | Software | 1 | 2023 | 665 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.140 |
Why?
| | Communicable Diseases | 1 | 2020 | 159 | 0.140 |
Why?
| | Alphapapillomavirus | 1 | 2017 | 39 | 0.140 |
Why?
| | Models, Theoretical | 3 | 2020 | 578 | 0.140 |
Why?
| | Biodiversity | 1 | 2020 | 409 | 0.130 |
Why?
| | Data Interpretation, Statistical | 2 | 2017 | 363 | 0.130 |
Why?
| | Androgen Antagonists | 1 | 2017 | 82 | 0.130 |
Why?
| | Neoplasm Grading | 1 | 2017 | 307 | 0.120 |
Why?
| | Treatment Failure | 1 | 2017 | 356 | 0.120 |
Why?
| | Adult | 13 | 2019 | 37929 | 0.120 |
Why?
| | Uncertainty | 2 | 2013 | 128 | 0.110 |
Why?
| | United States | 4 | 2019 | 14841 | 0.110 |
Why?
| | Cooking | 1 | 2015 | 62 | 0.110 |
Why?
| | Climate | 1 | 2015 | 94 | 0.110 |
Why?
| | Prevalence | 3 | 2023 | 2734 | 0.110 |
Why?
| | Epilepsy, Generalized | 1 | 2014 | 19 | 0.110 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2014 | 66 | 0.110 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 325 | 0.100 |
Why?
| | Mothers | 2 | 2012 | 754 | 0.100 |
Why?
| | Africa | 1 | 2013 | 108 | 0.100 |
Why?
| | Biological Evolution | 1 | 2017 | 474 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2804 | 0.100 |
Why?
| | Staphylococcal Skin Infections | 1 | 2013 | 35 | 0.100 |
Why?
| | Europe | 1 | 2013 | 414 | 0.100 |
Why?
| | Birth Certificates | 1 | 2012 | 10 | 0.100 |
Why?
| | Pregnancy Outcome | 2 | 2006 | 416 | 0.100 |
Why?
| | Communicable Disease Control | 1 | 2013 | 82 | 0.100 |
Why?
| | Adolescent | 7 | 2019 | 21513 | 0.090 |
Why?
| | Young Adult | 4 | 2019 | 13209 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1946 | 0.090 |
Why?
| | Massachusetts | 1 | 2012 | 172 | 0.090 |
Why?
| | Croatia | 1 | 2011 | 5 | 0.090 |
Why?
| | MEDLINE | 1 | 2011 | 21 | 0.090 |
Why?
| | Paternal Behavior | 1 | 2011 | 5 | 0.090 |
Why?
| | Air Pollution | 1 | 2015 | 316 | 0.090 |
Why?
| | Middle Aged | 6 | 2019 | 33479 | 0.090 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 62 | 0.080 |
Why?
| | Maternal Behavior | 1 | 2011 | 78 | 0.080 |
Why?
| | User-Computer Interface | 1 | 2011 | 159 | 0.080 |
Why?
| | Female | 15 | 2014 | 73304 | 0.080 |
Why?
| | Social Behavior Disorders | 1 | 2009 | 15 | 0.080 |
Why?
| | Prostatic Neoplasms | 1 | 2017 | 1043 | 0.080 |
Why?
| | Monoamine Oxidase | 1 | 2009 | 30 | 0.080 |
Why?
| | Calibration | 1 | 2009 | 146 | 0.080 |
Why?
| | Adolescent Behavior | 2 | 2011 | 530 | 0.070 |
Why?
| | Research Design | 1 | 2015 | 1139 | 0.070 |
Why?
| | Forests | 2 | 2020 | 62 | 0.070 |
Why?
| | Time | 1 | 2008 | 83 | 0.070 |
Why?
| | Research | 2 | 2015 | 451 | 0.070 |
Why?
| | Databases, Factual | 2 | 2011 | 1357 | 0.070 |
Why?
| | Tamoxifen | 1 | 2008 | 202 | 0.070 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2008 | 161 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 827 | 0.070 |
Why?
| | Infant | 2 | 2019 | 9465 | 0.070 |
Why?
| | Self-Assessment | 1 | 2007 | 72 | 0.060 |
Why?
| | Bioterrorism | 1 | 2006 | 30 | 0.060 |
Why?
| | Risperidone | 1 | 2006 | 30 | 0.060 |
Why?
| | Haloperidol | 1 | 2006 | 34 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2017 | 10811 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2017 | 7635 | 0.060 |
Why?
| | Markov Chains | 1 | 2006 | 126 | 0.060 |
Why?
| | Public Health Practice | 1 | 2006 | 70 | 0.060 |
Why?
| | Smoking Prevention | 1 | 2007 | 184 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2008 | 491 | 0.060 |
Why?
| | Fetal Development | 1 | 2009 | 296 | 0.060 |
Why?
| | Time Factors | 2 | 2014 | 6828 | 0.060 |
Why?
| | Benzodiazepines | 1 | 2006 | 155 | 0.060 |
Why?
| | Child, Preschool | 1 | 2019 | 11074 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2005 | 134 | 0.060 |
Why?
| | Prenatal Care | 1 | 2007 | 294 | 0.060 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2004 | 37 | 0.060 |
Why?
| | Disease Transmission, Infectious | 2 | 2020 | 62 | 0.060 |
Why?
| | Infertility | 1 | 2004 | 55 | 0.050 |
Why?
| | Aged | 4 | 2017 | 23961 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 115 | 0.050 |
Why?
| | Cohort Studies | 5 | 2014 | 5742 | 0.050 |
Why?
| | Pregnancy, Ectopic | 1 | 2003 | 53 | 0.050 |
Why?
| | Hospitalization | 2 | 2011 | 2199 | 0.050 |
Why?
| | Spodoptera | 1 | 2023 | 40 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2003 | 186 | 0.050 |
Why?
| | Child Welfare | 1 | 2004 | 216 | 0.050 |
Why?
| | ROC Curve | 1 | 2003 | 554 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2009 | 3556 | 0.040 |
Why?
| | Child | 2 | 2019 | 21935 | 0.040 |
Why?
| | Stochastic Processes | 1 | 2020 | 70 | 0.040 |
Why?
| | Male | 7 | 2017 | 67762 | 0.040 |
Why?
| | Prospective Studies | 2 | 2014 | 7604 | 0.040 |
Why?
| | Population Density | 1 | 2020 | 95 | 0.040 |
Why?
| | Biomarkers | 2 | 2009 | 4149 | 0.040 |
Why?
| | Decision Making | 1 | 2006 | 900 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2012 | 5778 | 0.040 |
Why?
| | North America | 1 | 2017 | 313 | 0.030 |
Why?
| | Fetal Monitoring | 1 | 1996 | 15 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 1996 | 39 | 0.030 |
Why?
| | Plant Leaves | 1 | 2017 | 147 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 1996 | 61 | 0.030 |
Why?
| | Ghana | 1 | 2015 | 38 | 0.030 |
Why?
| | Household Articles | 1 | 2015 | 24 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1060 | 0.030 |
Why?
| | Birth Weight | 2 | 2009 | 516 | 0.030 |
Why?
| | Equipment Design | 1 | 2015 | 522 | 0.030 |
Why?
| | Air Pollution, Indoor | 1 | 2015 | 180 | 0.020 |
Why?
| | Abdominal Injuries | 1 | 1994 | 123 | 0.020 |
Why?
| | Asthma | 1 | 2005 | 2295 | 0.020 |
Why?
| | Boston | 1 | 2012 | 91 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2014 | 513 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 395 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 499 | 0.020 |
Why?
| | Social Environment | 1 | 2011 | 296 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 108 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 375 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2008 | 389 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 352 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1509 | 0.020 |
Why?
| | Environment | 1 | 2009 | 358 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 510 | 0.020 |
Why?
| | Smallpox Vaccine | 1 | 2006 | 23 | 0.020 |
Why?
| | Civil Defense | 1 | 2006 | 19 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 436 | 0.020 |
Why?
| | Disaster Planning | 1 | 2006 | 91 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2005 | 171 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2008 | 1389 | 0.010 |
Why?
| | Endpoint Determination | 1 | 2004 | 77 | 0.010 |
Why?
| | Immunization | 1 | 2006 | 411 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1916 | 0.010 |
Why?
| | Linear Models | 1 | 2006 | 849 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2031 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2005 | 245 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2837 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 2892 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1477 | 0.010 |
Why?
| | Phenotype | 1 | 2009 | 3196 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2426 | 0.010 |
Why?
| | Child Development | 1 | 2004 | 475 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5131 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2005 | 552 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 6079 | 0.010 |
Why?
| | Cerebral Arteries | 1 | 1996 | 59 | 0.010 |
Why?
| | Umbilical Arteries | 1 | 1996 | 55 | 0.010 |
Why?
| | Risk Factors | 1 | 2009 | 10388 | 0.010 |
Why?
| | Yugoslavia | 1 | 1994 | 3 | 0.010 |
Why?
| | Arteries | 1 | 1996 | 269 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1996 | 474 | 0.010 |
Why?
| | Aorta | 1 | 1996 | 417 | 0.010 |
Why?
|
|
Dukic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|